HighTower Advisors
RVNC

HighTower Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-147,400
Closed -$765K 3689
2024
Q3
$765K Sell
147,400
-387,987
-72% -$2.01M ﹤0.01% 2092
2024
Q2
$1.38M Buy
535,387
+90,000
+20% +$231K ﹤0.01% 1663
2024
Q1
$2.19M Buy
445,387
+38,966
+10% +$192K ﹤0.01% 1385
2023
Q4
$3.57M Buy
406,421
+116,920
+40% +$1.03M 0.01% 1131
2023
Q3
$3.32M Buy
289,501
+94,451
+48% +$1.08M 0.01% 1107
2023
Q2
$4.94M Sell
195,050
-110,209
-36% -$2.79M 0.01% 911
2023
Q1
$9.83M Sell
305,259
-186,183
-38% -$6M 0.02% 634
2022
Q4
$9.07M Sell
491,442
-363,992
-43% -$6.72M 0.02% 643
2022
Q3
$23.1M Sell
855,434
-368,728
-30% -$9.96M 0.06% 304
2022
Q2
$16.9M Sell
1,224,162
-8,978
-0.7% -$124K 0.04% 391
2022
Q1
$24M Buy
1,233,140
+265,422
+27% +$5.18M 0.05% 332
2021
Q4
$15.8M Buy
967,718
+107,814
+13% +$1.76M 0.03% 451
2021
Q3
$24M Buy
859,904
+277,129
+48% +$7.72M 0.06% 295
2021
Q2
$17.3M Sell
582,775
-104,240
-15% -$3.09M 0.05% 344
2021
Q1
$19.2M Buy
687,015
+614,315
+845% +$17.2M 0.06% 309
2020
Q4
$2.06M Sell
72,700
-24,234
-25% -$687K 0.01% 900
2020
Q3
$2.44M Buy
96,934
+47,734
+97% +$1.2M 0.01% 809
2020
Q2
$1.2M Buy
49,200
+5,500
+13% +$134K 0.01% 1030
2020
Q1
$648K Buy
43,700
+2,700
+7% +$40K ﹤0.01% 1200
2019
Q4
$665K Buy
41,000
+12,800
+45% +$208K ﹤0.01% 1314
2019
Q3
$367K Buy
28,200
+1,000
+4% +$13K ﹤0.01% 1663
2019
Q2
$352K Buy
27,200
+1,200
+5% +$15.5K ﹤0.01% 1702
2019
Q1
$410K Buy
26,000
+6,000
+30% +$94.6K ﹤0.01% 1555
2018
Q4
$403K Sell
20,000
-2,000
-9% -$40.3K ﹤0.01% 1460
2018
Q3
$547K Hold
22,000
﹤0.01% 1414
2018
Q2
$604K Hold
22,000
﹤0.01% 1359
2018
Q1
$678K Hold
22,000
0.01% 1278
2017
Q4
$787K Buy
+22,000
New +$787K 0.01% 1235